Sabra Health Care Reit, INC Form 4 insider transactions

Sabra Health Care REIT, Inc. Director Jeffrey A. Malehorn was granted 8,178 restricted stock units, increasing his total beneficial ownership to 104,817 shares.

Ann Kono, a Director at Sabra Health Care REIT, Inc., was granted 8,178 restricted stock units as part of her compensation, aligning her interests with shareholders.

Sabra Health Care REIT, Inc. Director Lynne S. Katzmann was granted 8,178 restricted stock units, increasing her beneficial ownership to 74,592 shares.

Sabra Health Care REIT, Inc. Director Michael J. Foster reported the acquisition of 8,178 restricted stock units as part of the company's 2009 Performance Incentive Plan.

Sabra Health Care REIT, Inc. Director Catherine Cusack was granted 8,178 restricted stock units as part of her compensation, vesting over the next year.

Sabra Health Care REIT, Inc. Director Craig A. Barbarosh was granted 8,178 restricted stock units, aligning his interests with shareholders.

Sabra Health Care REIT, Inc. Director Clifton J Porter II acquired 827 common stock units through dividend equivalent payments, increasing his total beneficial ownership to 49,548 units.

Jeffrey A. Malehorn, a Director at Sabra Health Care REIT, Inc., acquired 914 common stock units as dividend equivalent payments, increasing his total beneficial ownership to 96,639 shares.

Sabra Health Care REIT, Inc. Director Ann Kono has reported an acquisition of 815 common stock units through dividend equivalent payments, increasing her total beneficial ownership to 48,331 units.

Lynne S. Katzmann, a Director at Sabra Health Care REIT, Inc. (SBRA), acquired 914 common stock units through dividend equivalent payments, increasing her total beneficial ownership to 66,414 units.

Michael J. Foster, a Director at Sabra Health Care REIT, Inc. (SBRA), has acquired 914 common stock units through dividend equivalent payments, increasing his direct beneficial ownership.

Catherine Cusack, a Director at Sabra Health Care REIT, Inc., has been credited with 805 additional common stock units as dividend equivalent payments, increasing her total beneficial ownership to 62,221 units.

Sabra Health Care REIT, Inc. Director Craig A. Barbarosh reported an acquisition of 914 common stock units through dividend equivalent payments, increasing his total beneficial ownership.

Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, Inc., was credited with 394 common stock units as dividend equivalent payments on May 30, 2025.

Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, Inc., was credited with 4,718 common stock units as dividend equivalent payments on existing equity awards.

Sabra Health Care REIT's Executive VP, CFO & Secretary, Michael Lourenco Costa, has increased his beneficial ownership in the company by acquiring 3,736 common stock units through dividend equivalent payments.

Sabra Health Care REIT's Chair, CEO, and President, Richard K. Matros, reported the acquisition of 14,197 common stock units through dividend equivalent payments, increasing his direct beneficial ownership to 841,437 units.

Director Michael J. Foster sold 11,000 shares of Sabra Health Care REIT, Inc. common stock at a price of $18.216 per share on May 20, 2025.

Director Clifton J. Porter II acquired 855 shares of Sabra Health Care REIT through dividend equivalent payments, increasing his total holdings to 48,721 shares.

Director Jeffrey A. Malehorn acquired 946 shares of Sabra Health Care REIT, Inc. through dividend equivalent payments, increasing his total holdings to 95,725 shares.

Director Ann Kono reports the acquisition of 843 stock units in Sabra Health Care REIT through dividend equivalent payments, increasing her total holdings to 47,516 shares.

Director Lynne S. Katzmann reported the acquisition of 946 shares of Sabra Health Care REIT common stock through dividend equivalent payments and the disposal of an unspecified amount of shares.

Director Michael Foster reports acquisition of 946 common stock units and disposals of common stock, along with adjustments to holdings in a 401(k) plan.

Catherine Cusack, a director of Sabra Health Care REIT, Inc., reported the acquisition of 833 common stock units due to dividend equivalent payments, increasing her total holdings to 61,416 shares.

Director Craig A. Barbarosh reports acquisition and disposal of Sabra Health Care REIT common stock, including dividend equivalent payments and transactions within a family trust.

Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, acquired 407 stock units through dividend equivalent payments on February 28, 2025.

Talya Nevo-Hacohen, Executive VP, CIO & Treasurer of Sabra Health Care REIT, reports acquisition of 4,874 shares of common stock due to dividend equivalent payments and adjustments to holdings in a trust.

Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reports acquisition of 3,858 shares of common stock due to dividend equivalent payments and adjustments to holdings in IRA accounts.

Richard K. Matros, Chair, CEO, and President of Sabra Health Care REIT, reports acquiring 14,676 common stock units due to dividend equivalent payments, increasing his direct holdings to 827,240 units.

Director Catherine Cusack recently increased her holdings in Sabra Health Care REIT, purchasing additional shares of common stock.